OpenBilldrug price receipt

NADAC week of 2026-10-14

RIVASTIGMINE 9.5 MG/24HR PATCH

For 1 patch

Pharmacies pay

$1.78 filed

1 × $1.78226 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$7.05 estimated

$1.78 + $0.27 (15%) + $5.00 fee per fill = $7.05

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

RIVASTIGMINE 9.5 MG/24HR PATCH is how the CMS NADAC file names this product. The FDA NDC Directory lists it as rivastigmine, under the trade name “Rivastigmine Transdermal System”.

FDA gives its dosage form as “patch” and “patch, extended release” and its route as transdermal.

FDA lists 6 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Sandoz Inc and Northstar Rx LLC.

FDA’s Established Pharmacologic Class for it is Cholinesterase Inhibitor.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes); the FDA directory lists 6 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1.78 for 1 patch (1 × $1.78226 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The 6 labelers

LabelerNDCsPharmacies pay per unit
Amneal Pharmaceuticals LLC1$1.78226 per EA filed
Breckenridge Pharmaceutical, Inc.1$1.78226 per EA filed
Mylan Pharmaceuticals Inc.1$1.78226 per EA filed
Northstar Rx LLC.1$1.78226 per EA filed
Sandoz Inc1$1.78226 per EA filed
Zydus Pharmaceuticals USA Inc.1$1.78226 per EA filed
Not listed as a package in the FDA directory5$1.78226 per EA filed
All 11 NDCs, with labeler and price
  • 00378-9071-16 · not listed as a package in the FDA directory · $1.78226 per EA · eff. 2026-09-23 filed
  • 00378-9071-93 · Mylan Pharmaceuticals Inc. · $1.78226 per EA · eff. 2026-09-23 filed
  • 00781-7309-31 · Sandoz Inc · $1.78226 per EA · eff. 2026-09-23 filed
  • 00781-7309-58 · not listed as a package in the FDA directory · $1.78226 per EA · eff. 2026-09-23 filed
  • 16714-0116-01 · not listed as a package in the FDA directory · $1.78226 per EA · eff. 2026-09-23 filed
  • 16714-0116-02 · Northstar Rx LLC. · $1.78226 per EA · eff. 2026-09-23 filed
  • 51991-0898-30 · Breckenridge Pharmaceutical, Inc. · $1.78226 per EA · eff. 2026-09-23 filed
  • 51991-0898-99 · not listed as a package in the FDA directory · $1.78226 per EA · eff. 2026-09-23 filed
  • 65162-0826-34 · Amneal Pharmaceuticals LLC · $1.78226 per EA · eff. 2026-09-23 filed
  • 70710-1197-01 · not listed as a package in the FDA directory · $1.78226 per EA · eff. 2026-09-23 filed
  • 70710-1197-07 · Zydus Pharmaceuticals USA Inc. · $1.78226 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

4 other products in the NADAC file share the FDA nonproprietary name rivastigmine with RIVASTIGMINE 9.5 MG/24HR PATCH.

ProductPharmacies pay per unitMedicare per unit
EXELON 4.6 MG/24HR PATCH
brand · patch, extended release
$21.87205 per EA filed
eff. 2026-09-23
$22.66382 per EA filed
Part D 2024 average
EXELON 9.5 MG/24HR PATCH
brand · patch, extended release
$21.80833 per EA filed
eff. 2026-09-23
$22.66382 per EA filed
Part D 2024 average
RIVASTIGMINE 4.6 MG/24HR PATCH
generic · patch / patch, extended release
$1.75167 per EA filed
eff. 2026-09-23
We don’t know yet
RIVASTIGMINE 9.5 MG/24HR PATCH this page
generic · patch / patch, extended release
$1.78226 per EA filed
eff. 2026-09-23
We don’t know yet
RIVASTIGMINE 13.3 MG/24HR PTCH
generic · patch / patch, extended release
$1.79594 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 11 NDCs’ NADAC prices is $1.78226 per EA filed.

Of the 28 other products in FDA’s Cholinesterase Inhibitor class priced per EA, 11 have a higher middle NADAC price and 17 a lower one. The one in the middle is GALANTAMINE ER 8 MG CAPSULE, at $0.80235 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 1 patch?
NADAC prices this product per EA, and the FDA NDC Directory lists 6 of its 11 NDCs (it does not list the other 5) as dosage forms “PATCH”, “PATCH, EXTENDED RELEASE” with route “TRANSDERMAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. So the card starts at 1 patch, priced per patch, rather than guess how many make up a fill; change it to match your prescription.